Single-dose vaccine production speeds up
Print Edition
CHINA is speeding up production of a single-dose COVID-19 vaccine in Shanghai, with annual production capacity of about 200 million units, it was revealed at the Shanghai Global Investment Promotion Conference.
Shanghai Pharmaceuticals CanSino Biologics will produce the one-shot vaccines in a factory in Baoshan District with an investment of 400 million yuan (US$62.5 million). Total investment in the project, which will cover COVID-19 and other vaccines, will reach 1.5 billion yuan. In February, CanSino announced that it has received conditional marketing approval for its single dose Recombinant Novel Coronavirus Vaccine, or Convidecia.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
